CAS 1062444-54-5

Formule : C16H17N5O5

InChI : InChI=1S/C16H17N5O5/c1-25-6-7-26-15-19-12(17)11-13(20-15)21(16(24)18-11)8-9-2-4-10(5-3-9)14(22)23/h2-5H,6-8H2,1H3,(H,18,24)(H,22,23)(H2,17,19,20)

Code InChI : ATISKRYGYNSRNP-UHFFFAOYSA-N

SMILES : COCCOC1=NC(=C2C(=N1)N(C(=O)N2)CC3=CC=C(C=C3)C(=O)O)N

1V209

CAS : 1062444-54-5

1V209

Formule : C₁₆H₁₇N₅O₅

Degré de pureté : ≥98%

Masse moléculaire : 359.34

Ref: 54-BUP04544

4-((6-Amino-2-(2-Methoxyethoxy)-8-Oxo-7,8-Dihydro-9H-Purin-9-Yl)Methyl)Benzoic Acid

CAS : 1062444-54-5

4-((6-Amino-2-(2-Methoxyethoxy)-8-Oxo-7,8-Dihydro-9H-Purin-9-Yl)Methyl)Benzoic Acid

Formule : C₁₆H₁₇N₅O₅

Degré de pureté : ≥98%

Masse moléculaire : 359.34

Ref: 54-OR1023217

1V209

CAS : 1062444-54-5

4-((6-Amino-2-(2-methoxyethoxy)-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl)benzoic acid

Formule : C₁₆H₁₇N₅O₅

Degré de pureté : 98%

Masse moléculaire : 359.34

Ref: IN-DG01136002

1V209

CAS : 1062444-54-5

1V209 (TLR7 agonist T7) is a Toll-like receptor 7 (TLR7) agonist and has anti-tumor effects.

Formule : C₁₆H₁₇N₅O₅

Degré de pureté : 99.61%

Couleur et forme : Solid

Masse moléculaire : 359.34

Ref: TM-T8316

4-((6-AMINO-2-(2-METHOXYETHOXY)-8-OXO-7,8-DIHYDRO-9H-PURIN-9-YL)METHYL)BENZOIC ACID

CAS : 1062444-54-5

Degré de pureté : 95%

Masse moléculaire : 359.3420105

Ref: 10-F840887

1V209

CAS : 1062444-54-5

1V209 is a vaccine adjuvant that has been shown to stimulate an antitumor response. It is a molecule that binds to toll-like receptor 4 (TLR4) on tumor cells, stimulating TLR4-mediated signaling pathways, which induces the production of death proteins. 1V209 also upregulates PD-L1 expression in tumor cells and activates the immune system to target and kill cancer cells. 1V209 may be used as a cancer therapy or as a vaccine adjuvant against infectious diseases such as hepatitis B, hepatitis C, and human immunodeficiency virus.

Formule : C₁₆H₁₇N₅O₅

Degré de pureté : Min. 95%

Masse moléculaire : 359.34 g/mol

Ref: 3D-MSB44454